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Notice to Public Health Officials and Clinicians: Recognizing, 
Managing, and Reporting Chikungunya Virus Infections in Travelers 
Returning from the Caribbean
Summary
On December 7, 2013, the World Health Organization (WHO) reported the first local (autochthonous) 
transmission of chikungunya virus in the Americas. As of December 12th, 10 cases of chikungunya have 
been confirmed in patients who reside on the French side of St. Martin in the Caribbean. Laboratory 
testing is pending on additional suspected cases. Onset of illness for confirmed cases was between 
October 15 and December 4. At this time, there are no reports of other suspected chikungunya cases 
outside St. Martin. However, further spread to other countries in the region is possible.
Chikungunya virus infection should be considered in patients with acute onset of fever and polyarthralgia, 
especially those who have recently traveled to the Caribbean. Healthcare providers are encouraged to 
report suspected chikungunya cases to their state or local health department to facilitate diagnosis and to 
mitigate the risk of local transmission.
Background
Chikungunya virus is a mosquito-borne alphavirus transmitted primarily by Aedes aegypti and Aedes 
albopictus mosquitoes. Humans are the primary reservoir during epidemics. Outbreaks have been 
documented in Africa, Southern Europe, Southeast Asia, the Indian subcontinent, and islands in the 
Indian and Pacific Oceans. Prior to the cases on St. Martin, the only chikungunya cases identified in the 
Americas were in travelers returning from endemic areas.
Clinical Disease
A majority of people infected with chikungunya virus become symptomatic. The incubation period is 
typically 3 -7  days (range, 2 -12 days). The most common clinical findings are acute onset of fever and 
polyarthralgia. Joint pains are often severe and debilitating. Other symptoms may include headache, 
myalgia, arthritis, or rash. Persons at risk for more severe disease include neonates (aged <1 month) 
exposed intrapartum, older adults (e.g., > 65 years), and persons with underlying medical conditions (e.g., 
hypertension, diabetes, or cardiovascular disease).
Diagnosis
Chikungunya virus infection should be considered in patients with acute onset of fever and polyarthralgia 
who recently returned from the Caribbean. Laboratory diagnosis is generally accomplished by testing 
serum to detect virus, viral nucleic acid, or virus-specific immunoglobulin M (IgM) and neutralizing 
antibodies. During the first week of illness, chikungunya virus infection can often be diagnosed by using 
viral culture or nucleic acid amplification on serum. Virus-specific IgM and neutralizing antibodies normally 
develop toward the end of the first week of illness. To definitively rule out the diagnosis, convalescent- 
phase samples should be obtained from patients whose acute-phase samples test negative.
Chikungunya virus diagnostic testing is performed at CDC, two state health departments (California and 
New York), and one commercial laboratory (Focus Diagnostics). Healthcare providers should contact their 
state or local health department to facilitate testing.
Treatment
No specific antiviral treatment is available for chikungunya fever. Treatment is generally palliative and can 
include rest, fluids, and use of analgesics and antipyretics. Because of similar geographic distribution and 
symptoms, patients with suspected chikungunya virus infections also should be evaluated and managed 
for possible dengue virus infection. People infected with chikungunya or dengue virus should be protected 
from further mosquito exposure during the first few days of illness to prevent other mosquitoes from 
becoming infected and reduce the risk of local transmission.
Prevention
No vaccine or preventive drug is available. The best way to prevent chikungunya virus infection is to 
avoid mosquito bites. Use air conditioning or screens when indoors. Use insect repellents and wear 
long sleeves and pants when outdoors. People at increased risk for severe disease should consider 
not traveling to areas with ongoing chikungunya outbreaks.
Recommendations for Health Care Providers and Public Health Practitioners
• Chikungunya virus infection should be considered in patients with acute onset of fever and 
polyarthralgia, especially those who have recently traveled to the Caribbean.
• Healthcare providers are encouraged to report suspected chikungunya cases to their state or local 
health department to facilitate diagnosis and to mitigate the risk of local transmission.
• Health departments should perform surveillance for chikungunya cases in returning travelers and be 
aware of the risk of possible local transmission in areas where Aedes species mosquitoes are 
currently active.
• State health departments are encouraged to report laboratory-confirmed chikungunya virus infections 
to ArboNET, the national surveillance system for arthropod-borne viruses.
For More Information
• General information about chikungunya virus and disease: http://www.cdc.gov/chikungunya/
• Chikungunya information for clinicians: http://www.cdc.gov/chikungunya/pdfs/CHIKV Clinicians.pdf
• Protection against mosquitoes: http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-2-the-pre-travel- 
consultation/protection-against-mosquitoes-ticks-and-other-insects-and-arthropods
• Travel notices related to chikungunya virus: http://wwwnc.cdc.gov/travel/notices
• Information about chikungunya for travelers and travel health providers: 
http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to- 
travel/chikungunya
• Chikungunya preparedness and response guidelines: 
http://new.paho.org/hq/index.php?option=com docman&task=doc download&gid=16984&Itemid
• Dengue clinical management guidelines: 
http://whqlibdoc.who.int/publications/2009/9789241547871 eng.pdf
The Centers fo r  Disease Control and Prevention (CDC) protects people’s health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 
issues; and promotes healthy living through strong partnerships with local, national, and international
organizations.
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